Colado, A., Almejún, M., Podaza, E., Risnik, D., Stanganelli, C., Elías, E., . . . Borge, M. The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Cita Chicago Style (17a ed.)Colado, A., et al. The Kinase Inhibitors R406 and GS-9973 Impair T Cell Functions and Macrophage-mediated Anti-tumor Activity of Rituximab in Chronic Lymphocytic Leukemia Patients.
Cita MLA (8a ed.)Colado, A., et al. The Kinase Inhibitors R406 and GS-9973 Impair T Cell Functions and Macrophage-mediated Anti-tumor Activity of Rituximab in Chronic Lymphocytic Leukemia Patients.
Precaución: Estas citas no son 100% exactas.